FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to a compound for the treatment of complement-mediated damage. Also disclosed is a composition comprising said compound for the treatment of complement-mediated damage. Method for preparing said composition and using said composition for the treatment of complement-mediated damage.
EFFECT: invention allows to effectively treat complement-mediated damage.
50 cl, 5 dwg, 9 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CELL-REACTIVE COMPOSTATIN ANALOGUES, LONG-ACTING COMPSTATIN ANALOGUES OR COMPUTED EFFECT ANALOGUES OF TARGETED ACTION AND RELATED COMPOSITIONS AND METHODS | 2013 |
|
RU2705215C2 |
| DOSING SCHEMES AND CORRESPONDING COMPOSITIONS AND METHODS | 2018 |
|
RU2779495C2 |
| INJECTION SCHEMES | 2016 |
|
RU2770099C2 |
| POTENT COMPSTATIN ANALOGS | 2012 |
|
RU2656102C2 |
| PROLONGED DELIVERY OF COMPSTATIN ANALOGUES FROM GELS | 2008 |
|
RU2505311C2 |
| EFFICIENT COMPSTATIN ANALOGUES | 2006 |
|
RU2474586C2 |
| AIMED AT UPARAP ANTIBODY-DRUG CONJUGATES | 2017 |
|
RU2740311C2 |
| METHODS FOR TREATING CANCER, INCLUDING TIGIT-BINDING AGENTS | 2017 |
|
RU2765410C2 |
| TACI-Fc FUSION PROTEIN AND ITS USE | 2019 |
|
RU2814988C2 |
| HUMAN NECTIN-2 SPECIFIC ANTIBODIES | 2020 |
|
RU2820275C2 |
